SEC Filing Details
Oct 30, 2018
Oct 25, 2018
Report of unscheduled material events or corporate event
KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.